TY - JOUR
T1 - The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
AU - the US Network of Pediatric MS Centers, the Canadian Pediatric Demyelinating Disease Network
AU - Tremlett, Helen
AU - Zhu, Feng
AU - Arnold, Douglas
AU - Bar-Or, Amit
AU - Bernstein, Charles N.
AU - Bonner, Christine
AU - Forbes, Jessica D.
AU - Graham, Morag
AU - Hart, Janace
AU - Knox, Natalie C.
AU - Marrie, Ruth Ann
AU - Mirza, Ali I.
AU - O’Mahony, Julia
AU - Van Domselaar, Gary
AU - Yeh, E. Ann
AU - Zhao, Yinshan
AU - Banwell, Brenda
AU - Waubant, Emmanuelle
N1 - Publisher Copyright:
© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association
PY - 2021/12
Y1 - 2021/12
N2 - Objective: To examine the gut microbiota in individuals with and without pediatric-onset multiple sclerosis (MS). Methods: We compared stool-derived microbiota of Canadian Pediatric Demyelinating Disease Network study participants ≤21 years old, with MS (disease-modifying drug [DMD] exposed and naïve) or monophasic acquired demyelinating syndrome [monoADS] (symptom onset <18 years), and unaffected controls. All were ≥30 days without antibiotics or corticosteroids. V4 region 16S RNA gene-derived amplicon sequence variants (Illumina MiSeq) were assessed using negative binomial regression and network analyses; rate ratios were age- and sex-adjusted (aRR). Results: Thirty-two MS, 41 monoADS (symptom onset [mean] = 14.0 and 6.9 years) and 36 control participants were included; 75%/56%/58% were female, with mean ages at stool sample = 16.5/13.8/15.1 years, respectively. Nine MS cases (28%) were DMD-naïve. Although microbiota diversity (alpha, beta) did not differ between participants (p > 0.1), taxa-level and gut community networks did. MS (vs. monoADS) exhibited > fourfold higher relative abundance of the superphylum Patescibacteria (aRR = 4.2;95%CI:1.6–11.2, p = 0.004, Q = 0.01), and lower abundances of short-chain fatty acid (SCFA)-producing Lachnospiraceae (Anaerosporobacter) and Ruminococcaceae (p, Q < 0.05). DMD-naïve MS cases were depleted for Clostridiales vadin-BB60 (unnamed species) versus either DMD-exposed, controls (p, Q < 0.01), or monoADS (p = 0.001, Q = 0.06) and exhibited altered community connectedness (p < 10−9 Kruskal–Wallis), with SCFA-producing taxa underrepresented. Consistent taxa-level findings from an independent US Network of Pediatric MS Centers case/control (n = 51/42) cohort included >eightfold higher abundance for Candidatus Stoquefichus and Tyzzerella (aRR = 8.8–12.8, p < 0.05) in MS cases and 72%–80% lower abundance of SCFA-producing Ruminococcaceae-NK4A214 (aRR = 0.38–0.2, p ≤ 0.01). Interpretation: Gut microbiota community structure, function and connectivity, and not just individual taxa, are of likely importance in MS.
AB - Objective: To examine the gut microbiota in individuals with and without pediatric-onset multiple sclerosis (MS). Methods: We compared stool-derived microbiota of Canadian Pediatric Demyelinating Disease Network study participants ≤21 years old, with MS (disease-modifying drug [DMD] exposed and naïve) or monophasic acquired demyelinating syndrome [monoADS] (symptom onset <18 years), and unaffected controls. All were ≥30 days without antibiotics or corticosteroids. V4 region 16S RNA gene-derived amplicon sequence variants (Illumina MiSeq) were assessed using negative binomial regression and network analyses; rate ratios were age- and sex-adjusted (aRR). Results: Thirty-two MS, 41 monoADS (symptom onset [mean] = 14.0 and 6.9 years) and 36 control participants were included; 75%/56%/58% were female, with mean ages at stool sample = 16.5/13.8/15.1 years, respectively. Nine MS cases (28%) were DMD-naïve. Although microbiota diversity (alpha, beta) did not differ between participants (p > 0.1), taxa-level and gut community networks did. MS (vs. monoADS) exhibited > fourfold higher relative abundance of the superphylum Patescibacteria (aRR = 4.2;95%CI:1.6–11.2, p = 0.004, Q = 0.01), and lower abundances of short-chain fatty acid (SCFA)-producing Lachnospiraceae (Anaerosporobacter) and Ruminococcaceae (p, Q < 0.05). DMD-naïve MS cases were depleted for Clostridiales vadin-BB60 (unnamed species) versus either DMD-exposed, controls (p, Q < 0.01), or monoADS (p = 0.001, Q = 0.06) and exhibited altered community connectedness (p < 10−9 Kruskal–Wallis), with SCFA-producing taxa underrepresented. Consistent taxa-level findings from an independent US Network of Pediatric MS Centers case/control (n = 51/42) cohort included >eightfold higher abundance for Candidatus Stoquefichus and Tyzzerella (aRR = 8.8–12.8, p < 0.05) in MS cases and 72%–80% lower abundance of SCFA-producing Ruminococcaceae-NK4A214 (aRR = 0.38–0.2, p ≤ 0.01). Interpretation: Gut microbiota community structure, function and connectivity, and not just individual taxa, are of likely importance in MS.
UR - https://www.scopus.com/pages/publications/85120964164
UR - https://www.scopus.com/pages/publications/85120964164#tab=citedBy
U2 - 10.1002/acn3.51476
DO - 10.1002/acn3.51476
M3 - Article
C2 - 34889081
AN - SCOPUS:85120964164
SN - 2328-9503
VL - 8
SP - 2252
EP - 2269
JO - Annals of Clinical and Translational Neurology
JF - Annals of Clinical and Translational Neurology
IS - 12
ER -